Scientists fight deadly childhood brain cancer with reinforced immune cells
NCT ID NCT03396575
Summary
This early-phase study tested a two-part immunotherapy for children newly diagnosed with a very aggressive brain stem tumor called DIPG. After standard radiation, doctors collected a patient's own tumor cells to train their immune cells to attack the cancer. These 'educated' immune cells were then given back to the patient, with the goal of boosting the body's natural defense against the tumor. The main goal was to see if this complex treatment was safe and feasible to deliver.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN STEM GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UF Health Shands Children's Hospital
Gainesville, Florida, 32610, United States
Conditions
Explore the condition pages connected to this study.